Thrivent Financial for Lutherans
RVMD icon

Thrivent Financial for Lutherans’s Revolution Medicines RVMD Stock Holding History

Thrivent Financial for Lutherans’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
7,200
-652
-8% -$95.2K ﹤0.01% 1814
2026
Q1 		$763K Buy
+7,852
New +$793K ﹤0.01% 2032
2021
Q1 		– Sell
-27,482
Closed -$1.09M – 2561
2020
Q4 		$1.09M Buy
+27,482
New +$1.09M ﹤0.01% 1697

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Thrivent Financial for Lutherans's RVMD Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Revolution Medicines (RVMD) stake by 8.3% in Q2 2026, selling an estimated $95.2K and leaving 7,200 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

Thrivent Financial for Lutherans first reported a position in RVMD in Q4 2020 and has held it in 3 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Thrivent Financial for Lutherans held 7,200 shares of Revolution Medicines worth $1.35M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 652 Revolution Medicines shares in Q2 2026, an estimated $95.2K.
  • Revolution Medicines made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1814 holding.
  • Thrivent Financial for Lutherans first reported a position in Revolution Medicines in Q4 2020 and has held it in 3 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.